ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW 656.00
+11.00 (1.71%)
At close: Jul 21, 2026
ABION Market Cap
ABION has a market cap or net worth of 59.11 billion as of July 21, 2026. Its market cap has decreased by -75.86% in one year.
Market Cap
59.11B
Enterprise Value
50.05B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
656.00
ChartMarket Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 59.11B, an increase of 7.70%. That is a compound annual growth rate of 0.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 59.11B | -79.04% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuadMedicine | 68.89B |
| CTCBIO | 67.90B |
| EyeGene | 64.11B |
| AriBioLab | 64.05B |
| KoBioLabs | 63.40B |
| PanGen Biotech | 61.69B |
| IMGT Co.,Ltd. | 55.14B |
| Naturalendo Tech | 54.87B |